These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14567885)

  • 21. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B; Eijkemans MJ; te Velde ER; Habbema JD; Fauser BC
    Fertil Steril; 2002 Jan; 77(1):91-7. PubMed ID: 11779596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
    Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
    Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
    Elnashar A; Fouad H; Eldosoky M; Saeid N
    Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment.
    van Santbrink EJ; Hohmann FP; Eijkemans MJ; Laven JS; Fauser BC
    Eur J Endocrinol; 2005 Apr; 152(4):611-7. PubMed ID: 15817918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
    Fridström M; Sjöblom P; Pousette A; Hillensjö T
    Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ovulation induction in anovulatory women].
    La Marca A; Bertucci E; Giulini S; Tirelli A; Malavasi B; Volpe A
    Minerva Ginecol; 2006 Dec; 58(6):489-97. PubMed ID: 17108879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualised gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: A prospective, observational study.
    Lauritsen MP; Loft A; Pinborg A; la Cour Freiesleben N; Cohen A; Petersen JH; Mikkelsen AL; Bjerge MR; Nyboe Andersen A
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():76-82. PubMed ID: 27960134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical therapeutic effects of acupuncture combined with Chinese herbal medicine on infertility of polycystic ovary syndrome in the patients with ovulation induction with letrozole].
    Yin Y; Zhang Y; Zhang H; Jiang D; Guo G
    Zhongguo Zhen Jiu; 2018 Jan; 38(1):27-32. PubMed ID: 29354933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovulation induction in normogonadotropic anovulation (PCOS).
    van Santbrink EJ; Fauser BC
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):261-70. PubMed ID: 16772156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2).
    Eijkemans MJ; Polinder S; Mulders AG; Laven JS; Habbema JD; Fauser BC
    Hum Reprod; 2005 Oct; 20(10):2830-7. PubMed ID: 16006473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
    Balen AH; Platteau P; Andersen AN; Devroey P; Sørensen P; Helmgaard L; Arce JC
    BJOG; 2006 Oct; 113(10):1195-202. PubMed ID: 16903840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
    Homburg R; Levy T; Ben-Rafael Z
    Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of ovulation by Sairei-to for polycystic ovary syndrome patients.
    Sakai A; Kondo Z; Kamei K; Izumi S; Sumi K
    Endocr J; 1999 Feb; 46(1):217-20. PubMed ID: 10426590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients.
    van Santbrink EJ; Donderwinkel PF; van Dessel TJ; Fauser BC
    Hum Reprod; 1995 May; 10(5):1048-53. PubMed ID: 7657739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response.
    Shokeir T; El-Kannishy G
    J Womens Health (Larchmt); 2008 Nov; 17(9):1445-52. PubMed ID: 18973428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
    Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
    Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.